{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:04:54Z","timestamp":1770462294256,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methylglyoxal (MGO) is a highly reactive dicarbonyl species that forms advanced glycation end products (AGEs). The binding of these AGEs to their receptor (RAGE) causes and sustains severe inflammation. Systemic inflammation is postulated to be a major driver in the progression of liver cirrhosis. However, the role of circulating MGO levels in liver cirrhosis remains unknown. In this study, we investigated the serum levels of two dicarbonyl species, MGO and glyoxal (GO) using tandem mass spectrometry (HPLC\u2013MS\/MS) and evaluated their association with disease severity. A total of 51 inpatients and outpatients with liver cirrhosis of mixed etiology and different disease stages were included. Elevated MGO levels were seen in an advanced stage of liver cirrhosis (p\u2009&lt;\u20090.001). High MGO levels remained independently associated with impaired liver function, as assessed by the model for end-stage liver disease (MELD) (\u03b2\u2009=\u20090.448, p\u2009=\u20090.002) and acute decompensation (AD) (\u03b2\u2009=\u20090.345, p\u2009=\u20090.005) scores. Furthermore, MGO was positively correlated with markers of systemic inflammation (IL-6, p\u2009=\u20090.004) and the development of ascites (p\u2009=\u20090.013). In contrast, no changes were seen in GO serum levels. Circulating levels of MGO are elevated in advanced stages of liver cirrhosis and are associated with impaired liver function and liver-related parameters.<\/jats:p>","DOI":"10.1038\/s41598-021-00119-7","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T15:30:38Z","timestamp":1634311838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Maurice","family":"Michel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Hilscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Moehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus-Alexander","family":"W\u00f6rns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"119_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad, A. A. et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 12, 145. https:\/\/doi.org\/10.1186\/s12916-014-0145-y (2014).","journal-title":"BMC Med."},{"key":"119_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis, E. A., Bosch, J. & Burroughs, A. K. Liver cirrhosis. The Lancet 383, 1749\u20131761. https:\/\/doi.org\/10.1016\/S0140-6736(14)60121-5 (2014).","journal-title":"The Lancet"},{"key":"119_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01374-X","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s, P. et al. Liver cirrhosis. The Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X (2021).","journal-title":"The Lancet."},{"key":"119_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D'Amico","year":"2018","unstructured":"D\u2019Amico, G. et al. Clinical states of cirrhosis and competing risks. J. Hepatol. 68, 563\u2013576. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020 (2018).","journal-title":"J. Hepatol."},{"key":"119_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi, M., Moreau, R., Angeli, P., Schnabl, B. & Arroyo, V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J. Hepatol. 63, 1272\u20131284. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.004 (2015).","journal-title":"J. Hepatol."},{"key":"119_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.048","author":"V Arroyo","year":"2020","unstructured":"Arroyo, V. et al. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.048 (2020).","journal-title":"J. Hepatol."},{"key":"119_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","volume":"42","author":"N Rabbani","year":"2012","unstructured":"Rabbani, N. & Thornalley, P. J. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 42, 1133\u20131142. https:\/\/doi.org\/10.1007\/s00726-010-0783-0 (2012).","journal-title":"Amino Acids"},{"key":"119_CR8","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/ijms18112466","volume":"18","author":"M Hollenbach","year":"2017","unstructured":"Hollenbach, M. The role of glyoxalase-I (Glo-I), advanced glycation endproducts (AGEs), and their receptor (RAGE) in chronic liver disease and hepatocellular carcinoma (HCC). International J. Mol. Sci. 18, 2466. https:\/\/doi.org\/10.3390\/ijms18112466 (2017).","journal-title":"International J. Mol. Sci."},{"key":"119_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cells8070749","volume":"8","author":"C Nigro","year":"2019","unstructured":"Nigro, C. et al. Dicarbonyl stress at the crossroads of healthy and unhealthy aging. Cells 8, 749. https:\/\/doi.org\/10.3390\/cells8070749 (2019).","journal-title":"Cells"},{"key":"119_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00249-016-1119-0","volume":"45","author":"A Shamsi","year":"2016","unstructured":"Shamsi, A., Amani, S., Alam, M. T. & Naeem, A. Aggregation as a consequence of glycation: Insight into the pathogenesis of arthritis. Eur. Biophys. J. 45, 523\u2013534. https:\/\/doi.org\/10.1007\/s00249-016-1119-0 (2016).","journal-title":"Eur. Biophys. J."},{"key":"119_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/iub.1471","volume":"68","author":"A Shamsi","year":"2016","unstructured":"Shamsi, A., Ahmed, A. & Bano, B. Glyoxal induced structural transition of buffalo kidney cystatin to molten globule and aggregates: Anti-fibrillation potency of quinic acid. IUBMB Life 68, 156\u2013166. https:\/\/doi.org\/10.1002\/iub.1471 (2016).","journal-title":"IUBMB Life"},{"key":"119_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk, C. G. & Stehouwer, C. D. A. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiol. Rev. 100, 407\u2013461. https:\/\/doi.org\/10.1152\/physrev.00001.2019 (2020).","journal-title":"Physiol. Rev."},{"key":"119_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijbiomac.2018.02.137","volume":"113","author":"A Ahmed","year":"2018","unstructured":"Ahmed, A., Shamsi, A., Khan, M. S., Husain, F. M. & Bano, B. Methylglyoxal induced glycation and aggregation of human serum albumin: Biochemical and biophysical approach. Int. J. Biol. Macromol. 113, 269\u2013276. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.02.137 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"119_CR14","doi-asserted-by":"publisher","first-page":"8735926","DOI":"10.1155\/2018\/8735926","volume":"2018","author":"I Knani","year":"2018","unstructured":"Knani, I. et al. Methylglyoxal: A relevant marker of disease activity in patients with rheumatoid arthritis. Dis. Mark. 2018, 8735926. https:\/\/doi.org\/10.1155\/2018\/8735926 (2018).","journal-title":"Dis. Mark."},{"key":"119_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","volume":"93","author":"N Rabbani","year":"2018","unstructured":"Rabbani, N. & Thornalley, P. J. Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 93, 803\u2013813. https:\/\/doi.org\/10.1016\/j.kint.2017.11.034 (2018).","journal-title":"Kidney Int."},{"key":"119_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fonc.2019.00785","volume":"9","author":"M Michel","year":"2019","unstructured":"Michel, M., Hollenbach, M., Pohl, S., Ripoll, C. & Zipprich, A. Inhibition of glyoxalase-I leads to reduced proliferation, migration and colony formation, and enhanced susceptibility to sorafenib in hepatocellular carcinoma. Front. Oncol. 9, 785. https:\/\/doi.org\/10.3389\/fonc.2019.00785 (2019).","journal-title":"Front. Oncol."},{"key":"119_CR17","doi-asserted-by":"publisher","first-page":"e0171260","DOI":"10.1371\/journal.pone.0171260","volume":"12","author":"M Hollenbach","year":"2017","unstructured":"Hollenbach, M. et al. Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis. PLoS ONE 12, e0171260. https:\/\/doi.org\/10.1371\/journal.pone.0171260 (2017).","journal-title":"PLoS ONE"},{"key":"119_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jhep.2004.08.007","volume":"41","author":"N Ahmed","year":"2004","unstructured":"Ahmed, N. et al. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J. Hepatol. 41, 913\u2013919. https:\/\/doi.org\/10.1016\/j.jhep.2004.08.007 (2004).","journal-title":"J. Hepatol."},{"key":"119_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s0168-8278(01)00232-x","volume":"36","author":"K \u0160ebekov\u00e1","year":"2002","unstructured":"\u0160ebekov\u00e1, K., Kup\u010dov\u00e1, V., Schinzel, R. & Heidland, A. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis\u2014Amelioration by liver transplantation. J. Hepatol. 36, 66\u201371. https:\/\/doi.org\/10.1016\/s0168-8278(01)00232-x (2002).","journal-title":"J. Hepatol."},{"key":"119_CR20","doi-asserted-by":"publisher","first-page":"501430","DOI":"10.1155\/2013\/501430","volume":"2013","author":"T Brenner","year":"2013","unstructured":"Brenner, T. et al. Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantation. Mediat. Inflamm. 2013, 501430. https:\/\/doi.org\/10.1155\/2013\/501430 (2013).","journal-title":"Mediat. Inflamm."},{"key":"119_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12953-018-0131-y","volume":"16","author":"C Spanos","year":"2018","unstructured":"Spanos, C. et al. Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease. Proteome Sci. 16, 4. https:\/\/doi.org\/10.1186\/s12953-018-0131-y (2018).","journal-title":"Proteome Sci."},{"key":"119_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: Mechanisms and clinical relevance. Gastroenterology 147, 765\u2013783. https:\/\/doi.org\/10.1053\/j.gastro.2014.07.018 (2014).","journal-title":"Gastroenterology"},{"key":"119_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cgh.2017.09.017","volume":"16","author":"J Remmler","year":"2018","unstructured":"Remmler, J. et al. Increased level of interleukin 6 associates with increased 90-day and 1-year mortality in patients with end-stage liver disease. Clin. Gastroenterol. Hepatol. 16, 730\u2013737. https:\/\/doi.org\/10.1016\/j.cgh.2017.09.017 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"119_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/apt.15515","volume":"50","author":"C Labenz","year":"2019","unstructured":"Labenz, C. et al. Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Aliment. Pharmacol. Ther. 50, 1112\u20131119. https:\/\/doi.org\/10.1111\/apt.15515 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"119_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","volume":"73","author":"C Bernsmeier","year":"2020","unstructured":"Bernsmeier, C., van der Merwe, S. & P\u00e9rianin, A. Innate immune cells in cirrhosis. J. Hepatol. 73, 186\u2013201. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.027 (2020).","journal-title":"J. Hepatol."},{"key":"119_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","volume":"21","author":"T Baumann","year":"2020","unstructured":"Baumann, T. et al. Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal. Nat. Immunol. 21, 555\u2013566. https:\/\/doi.org\/10.1038\/s41590-020-0666-9 (2020).","journal-title":"Nat. Immunol."},{"key":"119_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2690001","volume":"269","author":"PJ Thornalley","year":"1990","unstructured":"Thornalley, P. J. The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 269, 1\u201311. https:\/\/doi.org\/10.1042\/bj2690001 (1990).","journal-title":"Biochem. J."},{"key":"119_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1535370213477987","volume":"238","author":"C Masterjohn","year":"2013","unstructured":"Masterjohn, C. et al. Acute glutathione depletion induces hepatic methylglyoxal accumulation by impairing its detoxification to D-lactate. Exp. Biol. Med. 238, 360\u2013369. https:\/\/doi.org\/10.1177\/1535370213477987 (2013).","journal-title":"Exp. Biol. Med."},{"key":"119_CR29","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.2337\/db16-0153","volume":"65","author":"M Xue","year":"2016","unstructured":"Xue, M. et al. Improved glycemic control and vascular function in overweight and obese subjects by glyoxalase 1 inducer formulation. Diabetes 65, 2282\u20132294. https:\/\/doi.org\/10.2337\/db16-0153 (2016).","journal-title":"Diabetes"},{"key":"119_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cbi.2011.02.012","volume":"191","author":"K Yang","year":"2011","unstructured":"Yang, K. et al. Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity. Chem. Biol. Interact. 191, 322\u2013329. https:\/\/doi.org\/10.1016\/j.cbi.2011.02.012 (2011).","journal-title":"Chem. Biol. Interact."},{"key":"119_CR31","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.2337\/db09-0375","volume":"58","author":"SP Baba","year":"2009","unstructured":"Baba, S. P. et al. Reductive metabolism of AGE precursors: A metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 58, 2486\u20132497. https:\/\/doi.org\/10.2337\/db09-0375 (2009).","journal-title":"Diabetes"},{"key":"119_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jhep.2011.07.028","volume":"56","author":"KHJ Gaens","year":"2012","unstructured":"Gaens, K. H. J. et al. Endogenous formation of N\u03b5-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. J. Hepatol. 56, 647\u2013655. https:\/\/doi.org\/10.1016\/j.jhep.2011.07.028 (2012).","journal-title":"J. Hepatol."},{"key":"119_CR33","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","volume":"69","author":"M Bernardi","year":"2020","unstructured":"Bernardi, M. et al. Albumin in decompensated cirrhosis: New concepts and perspectives. Gut 69, 1127\u20131138. https:\/\/doi.org\/10.1136\/gutjnl-2019-318843 (2020).","journal-title":"Gut"},{"key":"119_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","volume":"72","author":"R Moreau","year":"2020","unstructured":"Moreau, R. et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J. Hepatol. 72, 688\u2013701. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.009 (2020).","journal-title":"J. Hepatol."},{"key":"119_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3932","author":"A Wang","year":"2019","unstructured":"Wang, A., Luan, H. H. & Medzhitov, R. An evolutionary perspective on immunometabolism. Science. https:\/\/doi.org\/10.1126\/science.aar3932 (2019).","journal-title":"Science"},{"key":"119_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","volume":"48","author":"PJ Beisswenger","year":"1999","unstructured":"Beisswenger, P. J., Howell, S. K., Touchette, A. D., Lal, S. & Szwergold, B. S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48, 198\u2013202. https:\/\/doi.org\/10.2337\/diabetes.48.1.198 (1999).","journal-title":"Diabetes"},{"key":"119_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1515\/cclm-2012-0878","volume":"52","author":"JLJM Scheijen","year":"2014","unstructured":"Scheijen, J. L. J. M. & Schalkwijk, C. G. Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: Evaluation of blood specimen. Clin. Chem. Lab. Med. 52, 85\u201391. https:\/\/doi.org\/10.1515\/cclm-2012-0878 (2014).","journal-title":"Clin. Chem. Lab. Med."},{"key":"119_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli, P. et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 69, 406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024 (2018).","journal-title":"J. Hepatol."},{"key":"119_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646\u2013649. https:\/\/doi.org\/10.1002\/bjs.1800600817 (1973).","journal-title":"Br. J. Surg."},{"issue":"Suppl","key":"119_CR40","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand, F. & Valla, D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J. Hepatol. 42(Suppl), S100\u2013S107. https:\/\/doi.org\/10.1016\/j.jhep.2004.11.015 (2005).","journal-title":"J. Hepatol."},{"key":"119_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/lt.20721","volume":"12","author":"S Habib","year":"2006","unstructured":"Habib, S. et al. MELD and prediction of post-liver transplantation survival. Liver Transplant. 12, 440\u2013447. https:\/\/doi.org\/10.1002\/lt.20721 (2006).","journal-title":"Liver Transplant."},{"key":"119_CR42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim, W. R. et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N. Engl. J. Med. 359, 1018\u20131026. https:\/\/doi.org\/10.1056\/NEJMoa0801209 (2008).","journal-title":"N. Engl. J. Med."},{"key":"119_CR43","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","volume":"62","author":"R Jalan","year":"2015","unstructured":"Jalan, R. et al. The CLIF consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J. Hepatol. 62, 831\u2013840. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.012 (2015).","journal-title":"J. Hepatol."},{"key":"119_CR44","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/nprot.2014.129","volume":"9","author":"N Rabbani","year":"2014","unstructured":"Rabbani, N. & Thornalley, P. J. Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS\/MS with corroborative prediction in physiological samples. Nat. Protoc. 9, 1969\u20131979. https:\/\/doi.org\/10.1038\/nprot.2014.129 (2014).","journal-title":"Nat. Protoc."},{"key":"119_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00414-012-0740-4","volume":"127","author":"C Hess","year":"2013","unstructured":"Hess, C. et al. Clinical and forensic examinations of glycaemic marker methylglyoxal by means of high performance liquid chromatography-tandem mass spectrometry. Int. J. Legal Med. 127, 385\u2013393. https:\/\/doi.org\/10.1007\/s00414-012-0740-4 (2013).","journal-title":"Int. J. Legal Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00119-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:36:06Z","timestamp":1670085366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00119-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00119-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20506"}}